Access to Probing and Peri-implant Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorArrow Development
About this trial
This multicenter cross-sectional study aims to evaluate the association between access to peri-implant probing and radiographic peri-implant bone loss. Although probing is the primary diagnostic tool for peri-implant diseases, prosthetic design may limit access, potentially affecting diagnosis and disease progression. The study will include patients with dental implants in function for at least three years and will assess clinical, radiographic, and prosthetic variables.
Eligibility criteria
Qualifiers
Age ≥18 years
Dental implants loaded for at least 3 years
Implant-supported restorations (single, partial fixed, or full-arch)
First visit to the clinic (maintenance, review, or treatment)
Disqualifiers
Exposure of the intraosseous portion of the implant
Evident prosthetic misfit
Inability to provide informed consent
Lack of cooperation for clinical examination
Trial design
Treatments tested in this trial
- Peri-implant probing
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Arrow Development
Lead sponsor
Salud y Estetica Dental SCH Zurbano S.L
Collaborator
Clinica Dental Nexus, Malaga
Collaborator
Clinica Bio, Madrid
Collaborator
Centro de Periodoncia e Implantes Aranda-Macera, Madrid
Collaborator
Clínica Sánchez Cortés, Madrid
Collaborator
Madrid Perio & Implant Clinic, Madrid
Collaborator
Clínica Barbieri, A Coruña
Collaborator
Clinica Ortiz-Vigon, Bilbao
Collaborator
PerioCentrum Guadalajara
Collaborator
Source ClinicalTrials.gov